Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLeukemiaLymphoma

Interventions

DRUG

motexafin gadolinium

Trial Locations (4)

The Mayo Clinic, Rochester

Northwestern University, Chicago

USC Norris Cancer Hospital, Los Angeles

Scripps Cancer Center, San Diego